About Us
Markets
Research
Services
NRI Corner
Fund Transfer
Select Link
MF Back Office-SB
MF Back Office-Client
Back Office - Client
Back Office - Sub Brokers
Backoffice – Family Login
Webmail
SPEEDe Login
BSE STAR MF
Branch Login
Create Account
About Us
Markets
Research
Services
Portfolio
NRI Cornor
Fund Transfer
Company Snapshot
Read it, Learn it and Do it for your investment Needs
Equity
Derivatives
Currency
Mutual Fund
IPO
Daily market Tracker
Market Analysis
News Analysis
Company profile
Corporate Actions
Other Market
ETF market Watch
Daily market Tracker
Daily market Tracker
Market Analysis
News Analysis
Company profile
Corporate Actions
Other Market
ETF market Watch
Get Quotes
Company Snapshot
Company Background
Board Of Directors
Peer Comparison
Technicals
+12 more
Score Board
Directors Report
MF Holding
Charts
Company News
History
Monthly High Low
Balance Sheet
Profit & Loss
Quarterly Results
Key Financial Ratios
Deliverable Volumes
Share Holdings Pattern
Bonus Issue
Demergers
Dividend
Mergers
Right Issues
Split Of Facevalue
Company Profile
Get Quotes
Company Snapshot
Company Background
Board Of Directors
Peer Comparison
Balance Sheet
Profit & Loss
Quarterly Results
Key Financial Ratios
Share Holdings Pattern
Charts
Company News
Directors Report
History
MF Holdings
Profit & Loss
Monthly High Low
Technicals
Deliverable Volumes
Bonus Issue
Demergers
Dividend
Mergers
Right Issues
Split Of Facevalue
Company News
Zydus Lifesciences Ltd
Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:
532321
NSE Symbol:
ZYDUSLIFE
P/E :
29.35
ISIN Demat:
INE010B01027
Div & Yield %:
0.09
EPS :
36.7
Book Value:
235.25
Market Cap (Rs. Cr.):
108,396.56
Face Value :
1
Date
Headline
20-May-26
Zydus Lifesciences concludes its investment in Torrent Urja 25
19-May-26
Board of Zydus Lifesciences approves share buyback of Rs 1,100 cr
13-May-26
Zydus Lifesciences announces cessation of director
09-May-26
Zydus Lifesciences to convene board meeting
06-May-26
Zydus' Ahmedabad unit completes USFDA inspection
16-Apr-26
Zydus clears USFDA inspection of its new isolator injectable line at Ahmedabad unit
10-Apr-26
Zydus improves ESG score to 68
08-Apr-26
Zydus receives USFDA approval for Dapagliflozin Tablets, 5 mg and 10 mg
21-Mar-26
Zydus launches Semaglutide injection under three brand names in India
19-Mar-26
Zydus launches India's first portable and foldable spacer - Aerolife Mini™
Prev
1
2
3
Next